Literature DB >> 10595412

Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog.

M R Schleiss1, A McGregor, N J Jensen, G Erdem, L Aktan.   

Abstract

The tegument phosphoproteins of human cytomegalovirus (HCMV) elicit cytotoxic T-lymphocyte (CTL) responses and are hence candidates for subunit vaccine development. Little is known, however, about the tegument proteins of nonhuman cytomegaloviruses, such as guinea pig CMV (GPCMV). DNA sequence analysis of the Eco R I "C" fragment of the GPCMV genome identified an open reading frame (ORF) which is colinear with that of the HCMV tegument phosphoprotein, UL83 (pp65). This ORF was found to have identity to HCMV UL83 and was predicted to encode a 565-amino-acid (aa) protein with a molecular mass of 62.3 kDa. Transcriptional analyses revealed that a GPCMV UL83 probe hybridized with both 2.2 kb and 4.2 kb mRNA species at 48 h post-infection (p.i.); synthesis of these messages was blocked by phosphonoacetic acid (PAA), defining these as "late" gene transcripts. In vitro translation of the UL83 ORF in reticulocyte lysate resulted in synthesis of a 65 kDa protein. Immunofluorescence experiments revealed that the putative GPCMV UL83 homolog exhibited a predominantly nuclear localization pattern. Polyclonal antisera were raised against a UL83/glutathione-S-transferase (GST) fusion protein. This antibody identified a 70-kDa virion-associated protein, the putative GPCMV UL83 homolog, in immunoblot and radioimmunoprecipitation experiments. Labeling experiments with 32P-orthophosphate indicated that the GPCMV UL83 protein is phosphorylated. Western blot analysis of glycerol tartrate gradient-purified virions and dense bodies confirmed that the putative GPCMV UL83 homolog was a constituent of both fractions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595412     DOI: 10.1023/a:1008136714136

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  35 in total

1.  Molecular characterization of the guinea-pig cytomegalovirus glycoprotein L gene.

Authors:  J C Paglino; R C Brady; M R Schleiss
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

Review 3.  Human cytomegalovirus structural proteins.

Authors:  R R Spaete; R C Gehrz; M P Landini
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

4.  Genomic location of a human cytomegalovirus protein with protein kinase activity (PK68).

Authors:  T Somogyi; S Michelson; M J Masse
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

5.  Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product.

Authors:  M J Gilbert; S R Riddell; B Plachter; P D Greenberg
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport.

Authors:  S Schmolke; P Drescher; G Jahn; B Plachter
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

9.  Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins.

Authors:  F J Rixon; C Addison; A McGregor; S J Macnab; P Nicholson; V G Preston; J D Tatman
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891

10.  Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein.

Authors:  A Gallina; L Simoncini; S Garbelli; E Percivalle; G Pedrali-Noy; K S Lee; R L Erikson; B Plachter; G Gerna; G Milanesi
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  13 in total

1.  New genes from old: redeployment of dUTPase by herpesviruses.

Authors:  Andrew J Davison; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Guinea pig cytomegalovirus GP84 is a functional homolog of the human cytomegalovirus (HCMV) UL84 gene that can complement for the loss of UL84 in a chimeric HCMV.

Authors:  A McGregor; K Y Choi; M R Schleiss
Journal:  Virology       Date:  2010-11-20       Impact factor: 3.616

3.  The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

Authors:  Mark R Schleiss; David I Bernstein; Michael A McVoy; Greg Stroup; Fernando Bravo; Blaine Creasy; Alistair McGregor; Kristin Henninger; Sabine Hallenberger
Journal:  Antiviral Res       Date:  2005-01       Impact factor: 5.970

Review 4.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

5.  Characterization of a cluster of late genes of guinea pig cytomegalovirus.

Authors:  Y Liu; B J Biegalke
Journal:  Virus Genes       Date:  2001-12       Impact factor: 2.332

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

7.  Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).

Authors:  Alistair McGregor; Fenyong Liu; Mark R Schleiss
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.

Authors:  Mark R Schleiss; Ryan Buus; K Yeon Choi; Alistair McGregor
Journal:  Future Virol       Date:  2013-12-01       Impact factor: 1.831

9.  Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.

Authors:  Alistair McGregor; K Yeon Choi; Xiaohong Cui; Michael A McVoy; Mark R Schleiss
Journal:  Antiviral Res       Date:  2008-02-14       Impact factor: 5.970

10.  Guinea pig cytomegalovirus protective T cell antigen GP83 is a functional pp65 homolog for innate immune evasion and pentamer dependent virus tropism.

Authors:  K Yeon Choi; Nadia El-Hamdi; Julia Hornig; Alistair McGregor
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.